Survey on brachytherapy training among radiation oncology residents in the German-speaking regions of Europe.


Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
09 2023
Historique:
received: 20 03 2023
accepted: 04 06 2023
medline: 28 8 2023
pubmed: 18 7 2023
entrez: 18 7 2023
Statut: ppublish

Résumé

This survey aimed to determine the perception of brachytherapy training among residents in the DACH region, consisting of Austria, Germany and Switzerland. An online questionnaire containing 22 questions related to trainee demographics (n = 5) and to brachytherapy training (n = 17) was sent in two iterations in 11/2019 and 02/2020. The following topics were evaluated: institutional support, barriers to training, extent of training, site-specific training (prostate, gynaecology, breast, gastrointestinal and skin), preferences for further training and outlook on overall development of brachytherapy. The responses were mostly based on a Likert scale of 1 to 5, thereby reflecting strength of opinion. Descriptive statistics were used to describe frequencies. Among the 108 respondents, approximately 69% of residents considered the ability to perform brachytherapy independently to be important or somewhat important. However, only 31% of respondents reported to have a dedicated brachytherapy training during residency. The major limitation to achieve independence in performing brachytherapy was seen in a low case load in Austria, in the lack of training in Switzerland and in both of them in Germany. The interest in brachytherapy training among residents in German-speaking countries was generally high, but there is a perceived lack of sufficient case volumes and partially also in formal training opportunities. Fellowships at departments with a high case load as part of a formalised curriculum and dedicated hands-on workshops at national or international conferences might help to overcome these issues.

Identifiants

pubmed: 37462693
doi: 10.1007/s00066-023-02108-3
pii: 10.1007/s00066-023-02108-3
pmc: PMC10450005
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

798-805

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 413668513

Informations de copyright

© 2023. The Author(s).

Références

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):624-8
pubmed: 27681758
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):438-9
pubmed: 26867872
Radiother Oncol. 2012 Apr;103(1):103-8
pubmed: 22444243
Strahlenther Onkol. 2023 Apr;199(4):370-378
pubmed: 36881115
J Contemp Brachytherapy. 2020 Feb;12(1):84-89
pubmed: 32190074
Pract Radiat Oncol. 2019 Sep - Oct;9(5):e465-e472
pubmed: 31128303
J Contemp Brachytherapy. 2022 Dec;14(6):501-511
pubmed: 36819467
Brachytherapy. 2018 Jul - Aug;17(4):653-659
pubmed: 29705049
Brachytherapy. 2021 Jul-Aug;20(4):695-700
pubmed: 33824052
Radiother Oncol. 2019 Dec;141:1-4
pubmed: 31495514
Radiother Oncol. 2018 Dec;129(3):415-416
pubmed: 30197152
Lancet. 2016 Jan 16;387(10015):229-38
pubmed: 26494415
Radiother Oncol. 2020 Jun;147:118-122
pubmed: 32276192
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):275-285
pubmed: 28262473
Curr Oncol Rep. 2016 Apr;18(4):26
pubmed: 26940059
Brachytherapy. 2020 Nov - Dec;19(6):812-819
pubmed: 31786168
Clin Transl Radiat Oncol. 2016 Dec 10;1:15-18
pubmed: 29657989
Lancet Oncol. 2021 Apr;22(4):538-547
pubmed: 33794207
J Med Imaging Radiat Oncol. 2022 Oct;66(7):980-992
pubmed: 35546425
Brachytherapy. 2020 Nov - Dec;19(6):857-860
pubmed: 32593558
Brachytherapy. 2020 Nov - Dec;19(6):767-776
pubmed: 32893145
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):557-560
pubmed: 30612963
Brachytherapy. 2013 Nov-Dec;12(6):622-7
pubmed: 23973187
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):257-283
pubmed: 30191859
Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):579-86
pubmed: 25151539
J Contemp Brachytherapy. 2019 Feb;11(1):48-53
pubmed: 30911310
Brachytherapy. 2020 Nov - Dec;19(6):777-782
pubmed: 33221261
Brachytherapy. 2022 Jan-Feb;21(1):1-3
pubmed: 34893430
Brachytherapy. 2021 Jan-Feb;20(1):128-135
pubmed: 33158776
IEEE Trans Biomed Eng. 2013 Apr;60(4):1002-12
pubmed: 23047861
Radiother Oncol. 2022 Dec;177:172-178
pubmed: 36328092
Brachytherapy. 2020 Nov - Dec;19(6):837-849
pubmed: 32978080
Cancer Radiother. 2020 Dec;24(8):876-881
pubmed: 32576437
Brachytherapy. 2020 Nov - Dec;19(6):827-836
pubmed: 32811761
Brachytherapy. 2020 Nov - Dec;19(6):732-737
pubmed: 33132072
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1175-1176
pubmed: 31327414

Auteurs

Johannes Knoth (J)

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürel 8-20, 1090, Vienna, Austria. johannes.knoth@meduniwien.ac.at.

Stefan Konrad (S)

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürel 8-20, 1090, Vienna, Austria.

Kristina Lössl (K)

Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Laura Motisi (L)

Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Matthias Mäurer (M)

Department for Radiotherapy and Radiation Oncology, University Hospital Jena, Friedrich-Schiller-University, Jena, Germany.
Clinician Scientist Program "OrganAge", Jena University Hospital, 07747, Jena, Germany.

Philipp Linde (P)

Department of Radiation Oncology, Cyberknife and Radiation Therapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener St 62, 50937, Cologne, Germany.

Katja Lindel (K)

Department of Radiation Oncology, Klinikum Karlsruhe, Karlsruhe, Germany.

Peter Niehoff (P)

Sana Klinikum Offenbach, Offenbach, Germany.

Vratislav Strnad (V)

Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany.

Alina Sturdza (A)

Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürel 8-20, 1090, Vienna, Austria.

Stefanie Corradini (S)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH